APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Angiopoietin 2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Angiopoietin 2 Industry Growth and Trends Forecast to 2032

Report ID 173963660126 December 2025104 pages

Choose your research edition.

Industry ResearchAngiopoietin 2 Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiopoietin 2 Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Angiopoietin 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiopoietin 2 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiopoietin 2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Angiopoietin 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiopoietin 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiopoietin 2 include Eli Lilly and Company, Amgen Inc., Synergys Biotherapeutics, Inc., Silence Therapeutics Plc, RXi Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc., MedImmune, LLC, F. Hoffmann-La Roche Ltd. and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Angiopoietin 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Angiopoietin 2 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Angiopoietin 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Angiopoietin 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Angiopoietin 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Angiopoietin 2 Market by Company

Eli Lilly and Company

Amgen Inc.

Synergys Biotherapeutics, Inc.

Silence Therapeutics Plc

RXi Pharmaceuticals Corporation

Regeneron Pharmaceuticals, Inc.

MedImmune, LLC

F. Hoffmann-La Roche Ltd.

Boehringer Ingelheim GmbH

AnGes MG, Inc.

Angiopoietin 2 Segment by Type

Atu-111

BI-836880

LY-3127804

MEDI-3617

Others

Angiopoietin 2 Segment by Application

Hospital

Clinic

Others

Angiopoietin 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiopoietin 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiopoietin 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiopoietin 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiopoietin 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Angiopoietin 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Atu-111 Table 2. Major Company of BI-836880 Table 3. Major Company of LY-3127804 Table 4. Major Company of MEDI-3617 Table 5. Major Company of Others Table 6. Global Angiopoietin 2 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 8. Global Angiopoietin 2 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Angiopoietin 2 Sales Market Share in Value by Type (2021-2026) Table 11. Global Angiopoietin 2 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Angiopoietin 2 Sales by Type (2027-2032) & (W Units) Table 13. Global Angiopoietin 2 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Angiopoietin 2 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Angiopoietin 2 Sales Market Share in Value by Type (2027-2032) Table 16. Global Angiopoietin 2 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 18. North America Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 20. Europe Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 24. Latin America Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Angiopoietin 2 Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Angiopoietin 2 Sales by Type (2021-2026) & (US$ Million) Table 27. Angiopoietin 2 Industry Trends Table 28. Angiopoietin 2 Industry Drivers Table 29. Angiopoietin 2 Industry Opportunities and Challenges Table 30. Angiopoietin 2 Industry Restraints Table 31. Global Angiopoietin 2 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Angiopoietin 2 Revenue Market Share by Company (2021-2026) Table 33. Global Angiopoietin 2 Sales by Company (2021-2026) & (W Units) Table 34. Global Angiopoietin 2 Sales Share by Company (2021-2026) Table 35. Global Angiopoietin 2 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Angiopoietin 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Angiopoietin 2 Major Company Production Sites and Headquarters Table 38. Global Angiopoietin 2 Company, Product Type & Application Table 39. Global Angiopoietin 2 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Angiopoietin 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Angiopoietin 2 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Angiopoietin 2 Sales by Region (2021-2026) & (W Units) Table 44. Global Angiopoietin 2 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Angiopoietin 2 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Angiopoietin 2 Sales Market Share in Value by Region (2021-2026) Table 47. Global Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Angiopoietin 2 Sales by Region (2027-2032) & (W Units) Table 49. Global Angiopoietin 2 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Angiopoietin 2 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Angiopoietin 2 Sales Market Share in Value by Region (2027-2032) Table 52. Global Angiopoietin 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Angiopoietin 2 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 55. Global Angiopoietin 2 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Angiopoietin 2 Sales Market Share in Value by Application (2021-2026) Table 58. Global Angiopoietin 2 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Angiopoietin 2 Sales by Application (2027-2032) & (W Units) Table 60. Global Angiopoietin 2 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Angiopoietin 2 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Angiopoietin 2 Sales Market Share in Value by Application (2027-2032) Table 63. Global Angiopoietin 2 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 65. North America Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 67. Europe Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 71. Latin America Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Angiopoietin 2 Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Angiopoietin 2 Sales by Application (2021-2026) & (US$ Million) Table 74. Eli Lilly and Company Company Information Table 75. Eli Lilly and Company Business Overview Table 76. Eli Lilly and Company Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Eli Lilly and Company Angiopoietin 2 Product Portfolio Table 78. Eli Lilly and Company Recent Development Table 79. Amgen Inc. Company Information Table 80. Amgen Inc. Business Overview Table 81. Amgen Inc. Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Amgen Inc. Angiopoietin 2 Product Portfolio Table 83. Amgen Inc. Recent Development Table 84. Synergys Biotherapeutics, Inc. Company Information Table 85. Synergys Biotherapeutics, Inc. Business Overview Table 86. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio Table 88. Synergys Biotherapeutics, Inc. Recent Development Table 89. Silence Therapeutics Plc Company Information Table 90. Silence Therapeutics Plc Business Overview Table 91. Silence Therapeutics Plc Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Silence Therapeutics Plc Angiopoietin 2 Product Portfolio Table 93. Silence Therapeutics Plc Recent Development Table 94. RXi Pharmaceuticals Corporation Company Information Table 95. RXi Pharmaceuticals Corporation Business Overview Table 96. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio Table 98. RXi Pharmaceuticals Corporation Recent Development Table 99. Regeneron Pharmaceuticals, Inc. Company Information Table 100. Regeneron Pharmaceuticals, Inc. Business Overview Table 101. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio Table 103. Regeneron Pharmaceuticals, Inc. Recent Development Table 104. MedImmune, LLC Company Information Table 105. MedImmune, LLC Business Overview Table 106. MedImmune, LLC Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. MedImmune, LLC Angiopoietin 2 Product Portfolio Table 108. MedImmune, LLC Recent Development Table 109. F. Hoffmann-La Roche Ltd. Company Information Table 110. F. Hoffmann-La Roche Ltd. Business Overview Table 111. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio Table 113. F. Hoffmann-La Roche Ltd. Recent Development Table 114. Boehringer Ingelheim GmbH Company Information Table 115. Boehringer Ingelheim GmbH Business Overview Table 116. Boehringer Ingelheim GmbH Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio Table 118. Boehringer Ingelheim GmbH Recent Development Table 119. AnGes MG, Inc. Company Information Table 120. AnGes MG, Inc. Business Overview Table 121. AnGes MG, Inc. Angiopoietin 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. AnGes MG, Inc. Angiopoietin 2 Product Portfolio Table 123. AnGes MG, Inc. Recent Development Table 124. North America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. North America Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 126. North America Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 127. North America Angiopoietin 2 Sales Forecast by Country (2027-2032) & (W Units) Table 128. North America Angiopoietin 2 Sales Market Share Forecast by Country (2027-2032) Table 129. North America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Angiopoietin 2 Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Angiopoietin 2 Market Share by Country (2021-2026) Table 132. North America Angiopoietin 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Angiopoietin 2 Market Share Forecast by Country (2027-2032) Table 134. Europe Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Europe Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 136. Europe Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 137. Europe Angiopoietin 2 Sales Forecast by Country (2027-2032) & (W Units) Table 138. Europe Angiopoietin 2 Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Angiopoietin 2 Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Angiopoietin 2 Market Share by Country (2021-2026) Table 142. Europe Angiopoietin 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Angiopoietin 2 Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 146. Asia-Pacific Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Angiopoietin 2 Sales Forecast by Country (2027-2032) & (W Units) Table 148. Asia-Pacific Angiopoietin 2 Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Angiopoietin 2 Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Angiopoietin 2 Market Share by Country (2021-2026) Table 152. Asia-Pacific Angiopoietin 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Angiopoietin 2 Market Share Forecast by Country (2027-2032) Table 154. Latin America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Latin America Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 156. Latin America Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 157. Latin America Angiopoietin 2 Sales Forecast by Country (2027-2032) & (W Units) Table 158. Latin America Angiopoietin 2 Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Angiopoietin 2 Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Angiopoietin 2 Market Share by Country (2021-2026) Table 162. Latin America Angiopoietin 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Angiopoietin 2 Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Angiopoietin 2 Sales by Country (2021-2026) & (W Units) Table 166. Middle East and Africa Angiopoietin 2 Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Angiopoietin 2 Sales Forecast by Country (2027-2032) & (W Units) Table 168. Middle East and Africa Angiopoietin 2 Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Angiopoietin 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Angiopoietin 2 Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Angiopoietin 2 Market Share by Country (2021-2026) Table 172. Middle East and Africa Angiopoietin 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Angiopoietin 2 Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Angiopoietin 2 Distributors List Table 177. Angiopoietin 2 Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Angiopoietin 2 Image Figure 2. Global Angiopoietin 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiopoietin 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiopoietin 2 Sales (2021-2032) & (W Units) Figure 5. Atu-111 Image Figure 6. Global Atu-111 Sales YoY Growth (2021-2032) & (W Units) Figure 7. BI-836880 Image Figure 8. Global BI-836880 Sales YoY Growth (2021-2032) & (W Units) Figure 9. LY-3127804 Image Figure 10. Global LY-3127804 Sales YoY Growth (2021-2032) & (W Units) Figure 11. MEDI-3617 Image Figure 12. Global MEDI-3617 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Angiopoietin 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Angiopoietin 2 Market Share by Type 2025 VS 2032 Figure 17. North America Angiopoietin 2 Sales Market Share in Volume by Type in 2025 Figure 18. North America Angiopoietin 2 Sales Market Share in Value by Type in 2025 Figure 19. Europe Angiopoietin 2 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Angiopoietin 2 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Angiopoietin 2 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Angiopoietin 2 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Angiopoietin 2 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Angiopoietin 2 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Angiopoietin 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Angiopoietin 2 Market Share by Application 2025 VS 2032 Figure 37. North America Angiopoietin 2 Sales Market Share in Volume by Application in 2025 Figure 38. North America Angiopoietin 2 Sales Market Share in Value by Application in 2025 Figure 39. Europe Angiopoietin 2 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Angiopoietin 2 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Angiopoietin 2 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Angiopoietin 2 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Angiopoietin 2 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Angiopoietin 2 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Angiopoietin 2 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Angiopoietin 2 Sales Market Share in Value by Application in 2025 Figure 47. North America Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Angiopoietin 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Angiopoietin 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Angiopoietin 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Angiopoietin 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Angiopoietin 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Angiopoietin 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Angiopoietin 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Angiopoietin 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Angiopoietin 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Angiopoietin 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Angiopoietin 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Angiopoietin 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Angiopoietin 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Angiopoietin 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Angiopoietin 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Angiopoietin 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Angiopoietin 2 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Angiopoietin 2 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Atu-111
  • BI-836880
  • LY-3127804
  • MEDI-3617
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Eli Lilly and Company
  • Amgen Inc.
  • Synergys Biotherapeutics, Inc.
  • Silence Therapeutics Plc
  • RXi Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals, Inc.
  • MedImmune, LLC
  • F. Hoffmann-La Roche Ltd.
  • Boehringer Ingelheim GmbH
  • AnGes MG, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiopoietin 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Angiopoietin 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Angiopoietin 2 Market by Type
  6. 1.3.1 Atu-111
  7. 1.3.2 BI-836880
  8. 1.3.3 LY-3127804
  9. 1.3.4 MEDI-3617
  10. 1.3.5 Others
  11. 1.4 Global Angiopoietin 2 Market Size by Type
  12. 1.4.1 Global Angiopoietin 2 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Angiopoietin 2 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Angiopoietin 2 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Angiopoietin 2 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Angiopoietin 2 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Angiopoietin 2 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Angiopoietin 2 Industry Trends
  2. 2.2 Angiopoietin 2 Industry Drivers
  3. 2.3 Angiopoietin 2 Industry Opportunities and Challenges
  4. 2.4 Angiopoietin 2 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Angiopoietin 2 Revenue (2021-2026)
  2. 3.2 Global Top Players by Angiopoietin 2 Sales (2021-2026)
  3. 3.3 Global Top Players by Angiopoietin 2 Price (2021-2026)
  4. 3.4 Global Angiopoietin 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiopoietin 2 Major Company Production Sites & Headquarters
  6. 3.6 Global Angiopoietin 2 Company, Product Type & Application
  7. 3.7 Global Angiopoietin 2 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiopoietin 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiopoietin 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiopoietin 2 Tier 1, Tier 2, and Tier 3
4 Angiopoietin 2 Regional Status and Outlook
  1. 4.1 Global Angiopoietin 2 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Angiopoietin 2 Historic Market Size by Region
  3. 4.2.1 Global Angiopoietin 2 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Angiopoietin 2 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Angiopoietin 2 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Angiopoietin 2 Forecasted Market Size by Region
  7. 4.3.1 Global Angiopoietin 2 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Angiopoietin 2 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Angiopoietin 2 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Angiopoietin 2 by Application
  1. 5.1 Angiopoietin 2 Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Angiopoietin 2 Market Size by Application
  6. 5.2.1 Global Angiopoietin 2 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Angiopoietin 2 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Angiopoietin 2 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Angiopoietin 2 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Angiopoietin 2 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Angiopoietin 2 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Angiopoietin 2 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Angiopoietin 2 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eli Lilly and Company
  2. 6.1.1 Eli Lilly and Company Company Information
  3. 6.1.2 Eli Lilly and Company Business Overview
  4. 6.1.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eli Lilly and Company Angiopoietin 2 Product Portfolio
  6. 6.1.5 Eli Lilly and Company Recent Developments
  7. 6.2 Amgen Inc.
  8. 6.2.1 Amgen Inc. Company Information
  9. 6.2.2 Amgen Inc. Business Overview
  10. 6.2.3 Amgen Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amgen Inc. Angiopoietin 2 Product Portfolio
  12. 6.2.5 Amgen Inc. Recent Developments
  13. 6.3 Synergys Biotherapeutics, Inc.
  14. 6.3.1 Synergys Biotherapeutics, Inc. Company Information
  15. 6.3.2 Synergys Biotherapeutics, Inc. Business Overview
  16. 6.3.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Portfolio
  18. 6.3.5 Synergys Biotherapeutics, Inc. Recent Developments
  19. 6.4 Silence Therapeutics Plc
  20. 6.4.1 Silence Therapeutics Plc Company Information
  21. 6.4.2 Silence Therapeutics Plc Business Overview
  22. 6.4.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Silence Therapeutics Plc Angiopoietin 2 Product Portfolio
  24. 6.4.5 Silence Therapeutics Plc Recent Developments
  25. 6.5 RXi Pharmaceuticals Corporation
  26. 6.5.1 RXi Pharmaceuticals Corporation Company Information
  27. 6.5.2 RXi Pharmaceuticals Corporation Business Overview
  28. 6.5.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Product Portfolio
  30. 6.5.5 RXi Pharmaceuticals Corporation Recent Developments
  31. 6.6 Regeneron Pharmaceuticals, Inc.
  32. 6.6.1 Regeneron Pharmaceuticals, Inc. Company Information
  33. 6.6.2 Regeneron Pharmaceuticals, Inc. Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals, Inc. Recent Developments
  37. 6.7 MedImmune, LLC
  38. 6.7.1 MedImmune, LLC Company Information
  39. 6.7.2 MedImmune, LLC Business Overview
  40. 6.7.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MedImmune, LLC Angiopoietin 2 Product Portfolio
  42. 6.7.5 MedImmune, LLC Recent Developments
  43. 6.8 F. Hoffmann-La Roche Ltd.
  44. 6.8.1 F. Hoffmann-La Roche Ltd. Company Information
  45. 6.8.2 F. Hoffmann-La Roche Ltd. Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Ltd. Recent Developments
  49. 6.9 Boehringer Ingelheim GmbH
  50. 6.9.1 Boehringer Ingelheim GmbH Company Information
  51. 6.9.2 Boehringer Ingelheim GmbH Business Overview
  52. 6.9.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim GmbH Angiopoietin 2 Product Portfolio
  54. 6.9.5 Boehringer Ingelheim GmbH Recent Developments
  55. 6.10 AnGes MG, Inc.
  56. 6.10.1 AnGes MG, Inc. Company Information
  57. 6.10.2 AnGes MG, Inc. Business Overview
  58. 6.10.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AnGes MG, Inc. Angiopoietin 2 Product Portfolio
  60. 6.10.5 AnGes MG, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Angiopoietin 2 Sales by Country
  2. 7.1.1 North America Angiopoietin 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Angiopoietin 2 Sales by Country (2021-2026)
  4. 7.1.3 North America Angiopoietin 2 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Angiopoietin 2 Market Size by Country
  6. 7.2.1 North America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Angiopoietin 2 Market Size by Country (2021-2026)
  8. 7.2.3 North America Angiopoietin 2 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Angiopoietin 2 Sales by Country
  2. 8.1.1 Europe Angiopoietin 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Angiopoietin 2 Sales by Country (2021-2026)
  4. 8.1.3 Europe Angiopoietin 2 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Angiopoietin 2 Market Size by Country
  6. 8.2.1 Europe Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Angiopoietin 2 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Angiopoietin 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Angiopoietin 2 Sales by Country
  2. 9.1.1 Asia-Pacific Angiopoietin 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Angiopoietin 2 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Angiopoietin 2 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Angiopoietin 2 Market Size by Country
  6. 9.2.1 Asia-Pacific Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Angiopoietin 2 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Angiopoietin 2 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Angiopoietin 2 Sales by Country
  2. 10.1.1 South America Angiopoietin 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Angiopoietin 2 Sales by Country (2021-2026)
  4. 10.1.3 South America Angiopoietin 2 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Angiopoietin 2 Market Size by Country
  6. 10.2.1 South America Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Angiopoietin 2 Market Size by Country (2021-2026)
  8. 10.2.3 South America Angiopoietin 2 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Angiopoietin 2 Sales by Country
  2. 11.1.1 Middle East and Africa Angiopoietin 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Angiopoietin 2 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Angiopoietin 2 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Angiopoietin 2 Market Size by Country
  6. 11.2.1 Middle East and Africa Angiopoietin 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Angiopoietin 2 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Angiopoietin 2 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Angiopoietin 2 Value Chain Analysis
  2. 12.1.1 Angiopoietin 2 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Angiopoietin 2 Production Mode & Process
  7. 12.2 Angiopoietin 2 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Angiopoietin 2 Distributors
  10. 12.2.3 Angiopoietin 2 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst